Texas Permanent School Fund Corp Has $581,000 Stock Position in Simulations Plus, Inc. (NASDAQ:SLP)

Texas Permanent School Fund Corp cut its stake in Simulations Plus, Inc. (NASDAQ:SLP) by 14.5% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,955 shares of the technology company’s stock after selling 2,025 shares during the period. Texas Permanent School Fund Corp owned 0.06% of Simulations Plus worth $581,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the company. Ophir Asset Management Pty Ltd bought a new stake in shares of Simulations Plus during the 4th quarter valued at about $7,156,000. Silvercrest Asset Management Group LLC bought a new position in shares of Simulations Plus during the 1st quarter worth approximately $4,717,000. Wasatch Advisors LP grew its position in shares of Simulations Plus by 36.5% during the 1st quarter. Wasatch Advisors LP now owns 381,693 shares of the technology company’s stock worth $15,707,000 after buying an additional 102,135 shares during the period. Congress Asset Management Co. MA lifted its position in shares of Simulations Plus by 34.6% during the 1st quarter. Congress Asset Management Co. MA now owns 171,490 shares of the technology company’s stock valued at $7,057,000 after acquiring an additional 44,129 shares during the period. Finally, SG Americas Securities LLC bought a new position in Simulations Plus during the second quarter worth $1,320,000. Institutional investors and hedge funds own 78.08% of the company’s stock.

Insider Activity at Simulations Plus

In other news, Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction dated Monday, July 1st. The shares were sold at an average price of $46.71, for a total value of $934,200.00. Following the sale, the director now directly owns 3,540,857 shares of the company’s stock, valued at $165,393,430.47. The sale was disclosed in a legal filing with the SEC, which is available at this link. In related news, Director Daniel L. Weiner sold 750 shares of the business’s stock in a transaction dated Friday, June 28th. The stock was sold at an average price of $49.32, for a total transaction of $36,990.00. Following the completion of the transaction, the director now directly owns 7,009 shares in the company, valued at $345,683.88. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Walter S. Woltosz sold 20,000 shares of the company’s stock in a transaction dated Monday, July 1st. The stock was sold at an average price of $46.71, for a total value of $934,200.00. Following the completion of the transaction, the director now owns 3,540,857 shares in the company, valued at $165,393,430.47. The disclosure for this sale can be found here. In the last three months, insiders have sold 60,750 shares of company stock worth $2,467,390. 20.90% of the stock is owned by company insiders.

Simulations Plus Stock Down 3.2 %

SLP opened at $31.23 on Friday. The company’s 50-day moving average price is $36.83 and its two-hundred day moving average price is $42.60. Simulations Plus, Inc. has a twelve month low of $30.95 and a twelve month high of $51.22. The stock has a market cap of $624.85 million, a price-to-earnings ratio of 65.06 and a beta of 0.70.

Simulations Plus (NASDAQ:SLP) last posted its quarterly earnings results on Tuesday, July 2nd. The technology company reported $0.19 earnings per share for the quarter, topping the consensus estimate of $0.15 by $0.04. The company had revenue of $18.54 million during the quarter, compared to the consensus estimate of $17.92 million. Simulations Plus had a return on equity of 7.80% and a net margin of 14.36%. The firm’s quarterly revenue was up 14.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.20 EPS. As a group, sell-side analysts anticipate that Simulations Plus, Inc. will post 0.51 earnings per share for the current year.

Simulations Plus Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, August 5th. Investors of record on Monday, July 29th were paid a dividend of $0.06 per share. The ex-dividend date of this dividend was Monday, July 29th. This represents a $0.24 dividend on an annualized basis and a dividend yield of 0.77%. Simulations Plus’s payout ratio is 50.00%.

Analyst Ratings Changes

A number of equities research analysts have commented on SLP shares. William Blair reissued an “outperform” rating on shares of Simulations Plus in a research note on Thursday, September 12th. Oppenheimer lifted their price target on shares of Simulations Plus from $55.00 to $65.00 and gave the company an “outperform” rating in a research report on Thursday, June 13th. Craig Hallum restated a “buy” rating and set a $56.00 price objective on shares of Simulations Plus in a report on Wednesday, July 3rd. KeyCorp initiated coverage on shares of Simulations Plus in a report on Monday, July 29th. They set an “overweight” rating and a $47.00 price objective for the company. Finally, JMP Securities initiated coverage on shares of Simulations Plus in a research report on Tuesday, July 16th. They set a “market perform” rating for the company. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $56.00.

Simulations Plus Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.